Drug details

Kitabis Pak (tobramycin inhalation solution for oral inhalation)

type of Aminoglycosides

Kitabis Pak (tobramycin) Inhalation Solution is an antibiotic used for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with P. aeruginosa.

The drug is often used to treat Cystic fibrosis .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• wheezing,
• cough,
• little or no urination,
• muscle weakness,
• swelling in your feet or ankles,
• chest tightness,
• ringing in your ears,
• spinning sensation,
• weak or shallow breathing,
• hearing problems,
• shortness of breath
• hoarse voice,
• severe dizziness,
• tiredness, and
• new or worsening breathing problems,
• balance problems,

The following drugs are related to Kitabis Pak, either as a replacement or used together:

• Acetylcysteine Solution (Mucomyst) (n-acetyl-l-cysteine)
• Creon (pancrelipase capsules)
• Creon 10 (pancrelipase delayed-released capsules)
• Creon 20 (pancrelipase delayed-released capsules)
• Creon 5 (pancrelipase delayed-release minimicrospheres)
• Pulmozyme (dornase alfa)
• Kalydeco (ivacaftor)
• Pancreaze (pancrelipase microtablets)